visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Mindimmune Therapeutics, Inc.

    Get Full Access

    Description

    • MindImmune Therapeutics, Inc. is a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system, including Alzheimers and Huntingtons disease, pain, and psychiatric disorders. It is increasingly clear that the central nervous system and the immune system are intimately integrated. Consequently, immune system dysfunction is a critical, often causative, factor in brain dysfunction. MindImmune scientists are at the forefront in recognizing the therapeutic opportunities in targeting the immune system to treat brain disease. MindImmune is based in Kingston, RI and is building an affiliation with the George & Anne Ryan Institute for Neuroscience at the University of Rhode Island to leverage the rapidly expanding Rhode Island ecosystem of academic neurosciences resources to advance its drug development programs.
    • location

      Headquarters: , Kingston, Rhode Island, United States

      More
    • Mindimmune Therapeutics, Inc. phone

      Phone Number:

    • Mindimmune Therapeutics, Inc. website

      Website:

    • Mindimmune Therapeutics, Inc. employees

      Employees:5

    • Mindimmune Therapeutics, Inc. revenue

      Revenue:$1 - 10M

    • Mindimmune Therapeutics, Inc. legal name

      Legal Name:Mindimmune Therapeutics, Inc.

    • Mindimmune Therapeutics, Inc.'s Social Media

      Mindimmune Therapeutics, Inc. linkedin
    • done Is this data correct?

    • |  NAICS Code: 541713  |

      Show More
    Person level website identification

    CEO for Mindimmune Therapeutics, Inc.

    Stevin Zorn

    President, Chief Executive Officer, Co-Founder

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Bob Nelson

    Vice President Of Exploratory Biology | Co-Founder

    Diane Gooding

    Director Of Business Operations, And Corporate Treasurer

    Frequently Asked Questions regarding Mindimmune Therapeutics, Inc.

    • What is Mindimmune Therapeutics, Inc.'s Revenue?

      Mindimmune Therapeutics, Inc.'s revenue is $1 - 10M

    • What is Mindimmune Therapeutics, Inc.'s NAICS code?

      Mindimmune Therapeutics, Inc.'s NAICS code is 541713

    • How many employees are working in Mindimmune Therapeutics, Inc.

      Mindimmune Therapeutics, Inc. has 5 employees

    • What is Mindimmune Therapeutics, Inc.'s Industry?

      Mindimmune Therapeutics, Inc. is in the industry of Biotechnology

    • Who is Mindimmune Therapeutics, Inc.'s CEO?

      Mindimmune Therapeutics, Inc.'s CEO is Stevin Zorn

    • Who is Mindimmune Therapeutics, Inc.'s Vice President Of Exploratory Biology | Co-Founder?

      Mindimmune Therapeutics, Inc.'s Vice President Of Exploratory Biology | Co-Founder is Bob Nelson

    • Who is Mindimmune Therapeutics, Inc.'s Director Of Business Operations, And Corporate Treasurer?

      Mindimmune Therapeutics, Inc.'s Director Of Business Operations, And Corporate Treasurer is Diane Gooding

    Company Directory